Global Blood
Stream Infection Testing Market, by Product Type (Instruments, Reagents, and
Others), by Technology (Conventional Testing and Non-conventional Testing), by
Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing,
Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals,
Independent Diagnostics Centers, and Others), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at
US$ 3,758.7 million in 2017, and is projected to exhibit a CAGR of 8.4% over
the forecast period (2019 – 2026), as highlighted in a new report published by.
Increasing prevalence of
abdominal infection, dental infection, kidney and urinary infection, and
chronic diseases is expected to augment the market growth Increasing prevalence
of abdominal infection and dental infection and growing geriatric population
are factors fueling the market growth. The Global Burden of Disease Study 2016
estimated that oral disease affects half of the world’s population i.e. 3.58
million people with dental carries. Globally it is estimated that 2.4 billion
people suffer from carries of permanent teeth. Moreover, high incidences of
burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with
growing awareness about hygiene is also expected to boost the global blood
stream infection testing market growth. According to World Health Organization,
at the end of 2017, approximately 36.9 million people living with HIV and 1.8
million people becoming newly infected in 2017 globally. Furthermore, advancements in diagnostic
testing is expected to fuel the market growth over the forecast period.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1727
For instance, in 2017,
researchers from the University of Illinois and Charle Foundation Hospital
completed a clinical study of a device that can detect sepsis from a single
drop of blood. In April 2017, BioMérieux, a major player in the field of in
vitro diagnostics, announced that BacT/ALERT VIRTUO, its fully automated blood
culture system, received 510(k) clearance from the U.S. Food and Drug Administration
(FDA). This innovative blood culture microbial detection system enhances the
blood culture performance for rapid detection, thereby offering faster
identification of bloodstream infection.
Browse 22 Market Data Tables and
20 Figures spread through 178 Pages and in-depth TOC on “Blood Stream Infection
Testing Market”- Global Forecast to 2026, by Product Type (Instruments,
Reagents, and Others), by Technology (Conventional Testing and Non-Conventional
Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic
Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User
(Hospitals, Independent Diagnostics Centers, and Others), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Key players in the market are
focused on launching new tests for detection of various infectious diseases.
For instance, in October 2018, Becton, Dickson and Company launched the
molecular test to detect the tuberculosis and multidrug resistant tuberculosis.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/blood-stream-infection-testing-market-1727
Key Takeaways of the Blood Stream
Infection Testing Market:
The global blood stream infection
testing market is expected to exhibit a CAGR of 8.4% over the forecast period,
owing to high prevalence of abdominal infections, dental infections, and
chronic diseases
Among product type, the
instruments segment held dominant position in the blood stream infection
testing market in 2018, owing to various new innovations by the key players for
synthesizing bloodstream infection tests to detect the infectious diseases.
Major companies operating in the
global blood stream infection testing market include, bioMérieux SA,
Becton,Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid
Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring,
AdvanDX, Siemens Healthcare.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1727
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment